发明名称 |
Transfer hydrogenation of cyclopamine analogs |
摘要 |
Provided herein is a process for the transfer-hydrogenation of ketone analogs of members of the jervine type of Veratrum alkaloids, such as cyclopamine. Also provided herein are novel ruthenium transfer-hydrogenation catalysts. |
申请公布号 |
US9394313(B2) |
申请公布日期 |
2016.07.19 |
申请号 |
US201113232851 |
申请日期 |
2011.09.14 |
申请人 |
Infinity Pharmaceuticals, Inc. |
发明人 |
Genov Daniel G.;Austad Brian C.;White Brian H. |
分类号 |
C07D491/048;C07F17/02 |
主分类号 |
C07D491/048 |
代理机构 |
McDermott Will & Emery LLP |
代理人 |
Evans Susan T.;McDermott Will & Emery LLP |
主权项 |
1. A process for preparing a compound of formula II-a: or a pharmaceutically acceptable salt form thereof; from a compound of formula I-a: or a pharmaceutically acceptable salt form thereof; wherein:
R1 is H or a nitrogen protecting group; the process comprising reacting a compound of formula (I-a) or a pharmaceutically acceptable salt form thereof with a hydrogen donor selected from the group consisting of methanol, ethanol, isopropanol, and t-butanol, in the presence of a ruthenium transfer-hydrogenation catalyst of formula (iii-a): wherein Ra and Rb are both either H or methyl; and
Rc is either H or C1-6 alkyl; to thereby provide a compound of formula (ii-a) or a pharmaceutically acceptable salt form thereof in a diastereomeric excess of greater than about 90% to about 99.5%. |
地址 |
Cambridge MA US |